Chemicals Management Plan (Canada)
Canada's programme for assessing and managing chemical substances, including risk assessment, risk management, and monitoring of priority substances.
Foresight tracks Chemicals Management Plan (Canada) developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
Cooling
45% below the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
6 May 2026, 19:30
Latest Chemicals Management Plan (Canada) alerts
The most recent regulatory and guidance signals tracked by Foresight
Canada Denies Request to Assess Desflurane under CEPA
In May 2026 Health Canada published a CEPA decision denying a public request to assess the anaesthetic desflurane, noting it is already covered by the broader PFAS class assessment. The decision confirms desflurane is treated as a toxic PFAS under CEPA and signals that any future risk management will come via wider PFAS measures rather than a separate substance-specific process.
CanadaCanada Issues CEPA SNAc Notice Nos. 22263/22318 for Hexanedioic Acid, 1,6-diisotridecyl Ester (CAS 26401-35-4)
In May 2026, Canada’s Minister of the Environment brought into force a Significant New Activity Notice under CEPA 1999 for diisotridecyl adipate (hexanedioic acid, 1,6-diisotridecyl ester, CAS 26401-35-4), making defined consumer and cosmetic uses subject to pre-notification and assessment. Companies planning to use this substance in Canadian consumer or cosmetic products must now factor in a 90-day SNAC notification lead time, detailed toxicity and exposure data requirements, and a tightening quantity threshold after May 2027 when assessing formulations, supply chains, and market access.
CanadaCanada Issues CEPA SNAc Notice No. 22262 for Alkanedioic Acid, Di-Branched Alkyl Ester in Consumer Products and Cosmetics
Canada has brought into force CEPA Significant New Activity Notice No. 22262, requiring prior notification for consumer and cosmetic uses of alkanedioic acid, di‑branched alkyl ester above 0.1%. Manufacturers and importers considering these applications now face a 90‑day SNAN lead time, transitional volume limits until May 2027, and potential new toxicology testing, which may delay or constrain formulations for Canadian consumer and cosmetic products.
CanadaCanada Opens Consultation on Proposed Restrictions for 1-Bromopropane in Consumer Products
In April 2026, Canada issued its final assessment for the Alkyl Halides Group and opened a consultation on a proposed risk management approach to restrict 1‑bromopropane in certain consumer products, with comments due by 24 June 2026. Companies using 1‑bromopropane in cleaning or automotive products should prepare for tighter Canadian controls, assess alternatives, and consider submitting data during the consultation to shape future CEPA regulations.
CanadaCanada Finalises CEPA Watch List Approach for Substances of Potential Concern
Canada has finalised the CEPA Watch List Approach, clarifying how Environment and Climate Change Canada and Health Canada will identify, list, and update substances of potential concern on the legislated Watch List. Although the Watch List itself imposes no new legal duties, being listed will signal elevated regulatory scrutiny and a higher likelihood of future assessments, data calls, and risk management, so companies using candidate substances should treat Watch List status as an early warning trigger for action.
CanadaCanada Issues Significant New Activity Notice No. 22295 for Phenol Derivative (CAS 155633-54-8)
In April 2026 Canada brought into force Significant New Activity Notice No. 22295 under the Canadian Environmental Protection Act for a benzotriazole phenol derivative (CAS 155633-54-8) used in consumer and cosmetic products. Any new or expanded consumer or cosmetic use above low face-cream concentrations will now require a 90-day pre-market notification and extensive reproductive toxicity data, with only a temporary 100 kg transitional threshold until April 2027, tightening future options for formulators and importers.
CanadaCanada Slow-Walks CEPA PFAS Toxic Listing Amid U.S. Trade Pressure
Canada’s proposal to list most PFAS as toxic under CEPA, published in March 2025, remains stalled in early 2026 while officials continue reviewing comments and the U.S. Trade Representative flags the pending rules in its 2026 trade-barrier report. The delay, under growing U.S. pressure and against a more aggressive EU PFAS phase-out, prolongs uncertainty over the timing and breadth of future PFAS bans and risk-management measures for Canadian and cross-border supply chains.
Canada
United States
European UnionCanada Adds Four Substances to the Domestic Substances List (SOR/2026-51)
Canada has adopted Order SOR/2026-51 adding four substances, including two named polymers and two CAS-identified chemicals, to the Domestic Substances List under the Canadian Environmental Protection Act, 1999, effective 18 March 2026. This formally moves these substances into Canada’s existing-substance regime under CEPA, meaning future manufacture or import will generally proceed under the standard DSL framework rather than new-substance notification, while leaving room for any later risk management if required.
CanadaCanada Adds Four Living Organisms To Domestic Substances List Under CEPA (SOR/2026-52)
Canada has added four living organisms, including a viral vector, human hematopoietic stem cells, and two therapeutic bacteriophages, to the Domestic Substances List under the Canadian Environmental Protection Act. This reclassification treats them as existing substances, removing New Substances Notification requirements for future manufacture or import and signalling continued expansion of Canada’s biotech regulatory baseline.
CanadaCanada Amends Non‑Domestic Substances List (Order 2026-66-01-02)
Canada expanded the Non-Domestic Substances List on April 4, 2026, adding numerous substances to Part I to streamline regulatory oversight. This update reduces notification and assessment burdens for importers and manufacturers, providing a more efficient pathway for market entry and supply chain planning.
CanadaCanada Plans Sunsetting of Chemicals Management Plan Funding
Canada is sunsetting dedicated Chemicals Management Plan funding and transitioning its activities into broader departmental operations starting in 2026. Compliance teams should anticipate potential delays in risk assessments and regulatory updates as resource constraints may force a reprioritization of chemical management activities.
CanadaCanada PMRA Opens Consultation on Cholecalciferol Rodent Baits (PRD2026-06)
Health Canada is consulting on the proposed registration of cholecalciferol-based rodenticides for commercial and domestic use through April 2026. Future market access will require compliance with strict risk-mitigation standards, specifically mandatory tamper-resistant bait stations and enhanced user-safety labeling.
CanadaCanada Updates Harmonized Substance Function and Application Codes for Reporting
Canada has updated its harmonized substance function and application codes for CEPA reporting to align with international OECD standards. Businesses must recalibrate internal data mapping to ensure accurate disclosure in future mandatory information-gathering notices and new substance notifications.
CanadaCanada Grants CEPA Waivers of Information Requirements for Certain Living Organism Notifications
Canada has granted information waivers to 15 companies for new living organism notifications, exempting them from specific ecotoxicity and pathogenicity testing. This reflects a strategic use of regulatory flexibility to accelerate market entry for biotechnology and pharmaceutical innovations while maintaining risk-based oversight.
CanadaCanada: Waivers Granted for Certain New-Substance Information Requirements Under CEPA 1999
Canada has issued case-by-case waivers for specific new-substance data requirements, exempting notified substances from certain toxicity and physical-chemical testing. This demonstrates continued regulatory flexibility for market entrants, allowing for reduced compliance costs when specific data is deemed unnecessary for risk assessment.
CanadaCanada: Order 2026-87-03-02 Removes Three Entries From the Non-Domestic Substances List
Canada has removed three substances from the Non-Domestic Substances List to facilitate their transition to the Domestic Substances List. This administrative shift reduces notification burdens for manufacturers and importers by treating these chemicals as domestic substances under the national regulatory framework.
CanadaCanada Adds 2-Ethylhexyl 2-Ethylhexanoate to Part 2 of Schedule 1 to CEPA 1999 (SOR/2026-47)
Canada formally designated 2-ethylhexyl 2-ethylhexanoate as a toxic substance under CEPA Schedule 1 effective March 2026. This listing triggers a legal requirement to develop risk management instruments that prioritize pollution prevention, signaling potential future prohibitions or strict use limits for chemical and consumer product manufacturers.
CanadaCanada Amends Domestic Substances List SNAc Requirements for 223 Substances Under CEPA 1999 (SOR/2026-43)
Canada has standardized Significant New Activity requirements for 223 substances on the Domestic Substances List, effective March 9, 2026. Manufacturers and importers must now provide 90-day advance notification for new activities, including specific concentration thresholds for consumer products and cosmetics.
CanadaCanada Announces Intent to Continue Federal Plastics Registry Reporting for 2027–2029
Canada has announced its intent to extend Federal Plastics Registry reporting requirements through 2029, signaling a long-term commitment to mandatory plastic data collection. Businesses should prepare for sustained reporting obligations and potential scope expansions, necessitating robust internal data tracking for evolving circular economy disclosures.
CanadaCanada Issues CEPA Ministerial Condition No. 22313 For Phenol, Methylstyrenated (CAS 68512-30-1)
Canada has imposed strict use and disposal conditions on phenol, methylstyrenated, limiting its application to controlled adhesive processes under the national environmental protection act. Manufacturers and importers must secure written compliance commitments from downstream users and maintain rigorous supply chain records to ensure continued market access for this substance.
CanadaNot a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Chemicals Management Plan (Canada) alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
